{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:30:57Z","timestamp":1761611457728,"version":"3.40.5"},"reference-count":168,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jcardioanesthesia.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1053\/j.jvca.2018.08.019","type":"journal-article","created":{"date-parts":[[2018,8,13]],"date-time":"2018-08-13T06:22:02Z","timestamp":1534141322000},"page":"1407-1419","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Natriuretic Peptides in Cardiac Anesthesia and Intensive Care"],"prefix":"10.1053","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8886-7175","authenticated-orcid":false,"given":"Lev A.","family":"Krichevskiy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1910-0207","authenticated-orcid":false,"given":"Igor A.","family":"Kozlov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.jvca.2018.08.019_bib0001","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/978-3-540-68964-5_15","article-title":"Natriuretic peptides: Their structures, receptors, physiologic functions and therapeutic applications","volume":"191","author":"Potter","year":"2009","journal-title":"Handb Exp Pharmacol"},{"key":"10.1053\/j.jvca.2018.08.019_bib0002","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1042\/CS20150469","article-title":"The natriuretic peptides system in the pathophysiology of heart failure: From molecular basis to treatment","volume":"130","author":"Volpe","year":"2016","journal-title":"Clin Sci"},{"key":"10.1053\/j.jvca.2018.08.019_bib0003","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13036-017-0093-0","article-title":"Synthesis, secretion, function, metabolism and application of natriuretic peptides in heart failure","volume":"12","author":"Fu","year":"2018","journal-title":"J Biol Eng"},{"key":"10.1053\/j.jvca.2018.08.019_bib0004","first-page":"927","article-title":"NT-pro CNP level estimation; Its experimental and clinical relevance","volume":"6","author":"Tyagi","year":"2017","journal-title":"Intern J Sci Res"},{"key":"10.1053\/j.jvca.2018.08.019_bib0005","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1006\/bbrc.2001.5419","article-title":"Identification of amino-terminal pro-C-type natriuretic peptide in human plasma","volume":"286","author":"Prickett","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1053\/j.jvca.2018.08.019_bib0006","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.ehj.2004.06.005","article-title":"BNP in acute coronary syndromes: The heart expresses its suffering","volume":"25","author":"Larsen","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1053\/j.jvca.2018.08.019_bib0007","first-page":"e137","volume":"8","author":"Yancy","year":"2017","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2018.08.019_bib0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0002-9343(64)90144-5","article-title":"The heart as an endocrine organ","volume":"36","author":"Braunwald","year":"1964","journal-title":"Am J Med"},{"key":"10.1053\/j.jvca.2018.08.019_bib0009","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1161\/01.RES.4.1.85","article-title":"Evidence of the atrial location of receptors influencing urine flow","volume":"4","author":"Henry","year":"1956","journal-title":"Circ Res"},{"key":"10.1053\/j.jvca.2018.08.019_bib0010","first-page":"99","article-title":"Electron microscopy of the atrium of the heart","volume":"14","author":"Kisch","year":"1956","journal-title":"I. Guinea pig. Exp Med Surg"},{"key":"10.1053\/j.jvca.2018.08.019_bib0011","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0024-3205(81)90370-2","article-title":"A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats","volume":"28","author":"De Bold","year":"1981","journal-title":"Life Sci"},{"key":"10.1053\/j.jvca.2018.08.019_bib0012","first-page":"F863","article-title":"Effects of synthetic atrial natriuretic factor on renal function and renin release","volume":"247","author":"Burnett","year":"1984","journal-title":"Am J Physiol"},{"key":"10.1053\/j.jvca.2018.08.019_bib0013","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1253\/circj.CJ-17-0499","article-title":"Atrial natriuretic peptide. Old but new therapeutic in cardiovascular diseases","volume":"81","author":"Ichiki","year":"2017","journal-title":"Circ J"},{"key":"10.1053\/j.jvca.2018.08.019_bib0014","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/332078a0","article-title":"A new natriuretic peptide in porcine brain","volume":"332","author":"Sudoh","year":"1988","journal-title":"Nature"},{"key":"10.1053\/j.jvca.2018.08.019_bib0015","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/0006-291X(90)92401-K","article-title":"C-type natriuretic peptide (CNP): A new member of natriuretic peptide family identified in porcine brain","volume":"168","author":"Sudoh","year":"1990","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1053\/j.jvca.2018.08.019_bib0016","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.peptides.2005.06.019","article-title":"Regional sampling and the effects of experimental heart failure in sheep: Differential responses in A, B and C-type natriuretic peptides","volume":"27","author":"Charles","year":"2006","journal-title":"Peptides"},{"key":"10.1053\/j.jvca.2018.08.019_bib0017","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.ejheart.2004.12.009","article-title":"C-type natriuretic peptide plasma levels increase in patients with chronic heart failure as a function of clinical severity","volume":"7","author":"Del Ry","year":"2005","journal-title":"Eur J Heart Fail"},{"key":"10.1053\/j.jvca.2018.08.019_bib0018","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1161\/01.CIR.0000047280.15244.EB","article-title":"Myocardial production of C-type natriuretic peptide in chronic heart failure","volume":"107","author":"Kalra","year":"2003","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2018.08.019_bib0019","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0196-9781(95)02099-3","article-title":"Binding of CNP-22 and CNP-53 to cultured mouse astrocytes and effects on cyclic GMP","volume":"17","author":"Yeung","year":"1996","journal-title":"Peptides"},{"key":"10.1053\/j.jvca.2018.08.019_bib0020","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0008-6363(01)00331-5","article-title":"The renal urodilatin system: Clinical implications","volume":"51","author":"Forssmann","year":"2001","journal-title":"Cardiovasc Res"},{"key":"10.1053\/j.jvca.2018.08.019_bib0021","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1253\/circj.CJ-16-1282","article-title":"B-type natriuretic peptide in heart failure with preserved ejection fraction \u2013 relevance to age-related left ventricular modeling in japanese","volume":"81","author":"Harada","year":"2017","journal-title":"Circ J"},{"key":"10.1053\/j.jvca.2018.08.019_bib0022","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jacc.2003.07.037","article-title":"Elevation of plasma brain natriuretic peptide is a hallmark of diastolic heart failure independent of ventricular hypertrophy","volume":"43","author":"Yamaguchi","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jvca.2018.08.019_bib0023","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1093\/eurheartj\/ehu067","article-title":"Heart failure with preserved ejection fraction: A clinical dilemma","volume":"35","author":"Komajda","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1053\/j.jvca.2018.08.019_bib0024","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1111\/j.1742-4658.2011.08082.x","article-title":"Natriuretic peptide metabolism, clearance and degradation","volume":"278","author":"Potter","year":"2011","journal-title":"FEBS J"},{"key":"10.1053\/j.jvca.2018.08.019_bib0025","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002423","article-title":"Natriuretic peptides in the regulation of cardiovascular physiology and metabolic events","volume":"4","author":"Kerkel\u00e4","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"10.1053\/j.jvca.2018.08.019_bib0026","doi-asserted-by":"crossref","first-page":"21594","DOI":"10.1074\/jbc.M501103200","article-title":"Local atrial natriuretic peptide signaling prevents hypertensive cardiac hypertrophy in endothelial nitric-oxide synthase-deficient mice","volume":"280","author":"Bubikat","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1053\/j.jvca.2018.08.019_bib0027","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1172\/JCI17061","article-title":"Pressure-independent cardiac hypertrophy in mice with cardiomyocyte-restricted inactivation of the atrial natriuretic peptide receptor guanylyl cyclase-A","volume":"111","author":"Holtwick","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1053\/j.jvca.2018.08.019_bib0028","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1172\/JCI11273","article-title":"Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A-deficient mice","volume":"107","author":"Knowles","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1053\/j.jvca.2018.08.019_bib0029","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1161\/01.CIR.77.4.849","article-title":"Atrial natriuretic factor potentiates forearm reflex vasoconstriction induced by cardiopulmonary receptor deactivation in man","volume":"77","author":"Volpe","year":"1988","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2018.08.019_bib0030","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1161\/01.CIR.82.4.1214","article-title":"Converting enzyme inhibition prevents the effects of atrial natriuretic factor on baroreflex responses in humans","volume":"82","author":"Volpe","year":"1990","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2018.08.019_bib0031","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1161\/01.RES.0000117070.86556.9F","article-title":"B-type natriuretic peptide exerts broad functional opposition to transforming growth factor-beta in primary human cardiac fibroblasts: Fibrosis, myofibroblast conversion, proliferation, and inflammation","volume":"94","author":"Kapoun","year":"2004","journal-title":"Circ Res"},{"key":"10.1053\/j.jvca.2018.08.019_bib0032","first-page":"90","article-title":"A cross-talk between the renin-angiotensin and adrenergic systems in cardiovascular health and disease","volume":"1","author":"Stupin","year":"2017","journal-title":"Southeast Eur Med J"},{"key":"10.1053\/j.jvca.2018.08.019_bib0033","doi-asserted-by":"crossref","first-page":"23060","DOI":"10.1016\/S0021-9258(18)54463-X","article-title":"Extracellular domain-IgG fusion proteins for three human natriuretic peptide receptors. Hormone pharmacology and application to solid phase screening of synthetic peptide antisera","volume":"266","author":"Bennett","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1053\/j.jvca.2018.08.019_bib0034","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1126\/science.1672777","article-title":"Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP)","volume":"252","author":"Koller","year":"1991","journal-title":"Science"},{"key":"10.1053\/j.jvca.2018.08.019_bib0035","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1210\/endo.130.1.1309330","article-title":"Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide","volume":"130","author":"Suga","year":"1992","journal-title":"Endocrinology"},{"key":"10.1053\/j.jvca.2018.08.019_bib0036","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1042\/bj3580379","article-title":"Evidence for a novel natriuretic peptide receptor that prefers brain natriuretic peptide over atrial natriuretic peptide","volume":"358","author":"Goy","year":"2001","journal-title":"Biochem J"},{"key":"10.1053\/j.jvca.2018.08.019_bib0037","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/01.RES.86.8.841","article-title":"Functional deletion mutation of the 5\u201d-flanking region of type A human natriuretic peptide receptor gene and its association with essential hypertension and left ventricular hypertrophy in the Japanese","volume":"86","author":"Nakayama","year":"2000","journal-title":"Circ Res"},{"key":"10.1053\/j.jvca.2018.08.019_bib0038","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1042\/bj1370477","article-title":"The purification and specificity of a neutral endopeptidasefrom rabbit kidney brush border","volume":"137","author":"Kerr","year":"1974","journal-title":"Biochem J"},{"key":"10.1053\/j.jvca.2018.08.019_bib0039","doi-asserted-by":"crossref","first-page":"366","DOI":"10.2310\/6650.2005.53709","article-title":"Natriuretic peptides in acute and chronic kidney disease and during renal replacement therapy","volume":"53","author":"H\u00f6rl","year":"2005","journal-title":"J Investig Med"},{"key":"10.1053\/j.jvca.2018.08.019_bib0040","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.2215\/CJN.00850208","article-title":"Natriuretic peptides in chronic kidney disease","volume":"3","author":"Tagore","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.jvca.2018.08.019_bib0041","doi-asserted-by":"crossref","first-page":"F167","DOI":"10.1152\/ajprenal.00259.2002","article-title":"Natriuretic peptides and acute renal failure","volume":"285","author":"Vesely","year":"2003","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1053\/j.jvca.2018.08.019_bib0042","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1373\/clinchem.2003.030692","article-title":"Elimination of the cardiac natriuretic peptides B-type natriuretic peptide (BNP) and N-terminal proBNP by hemodialysis","volume":"50","author":"Wahl","year":"2004","journal-title":"Clin Chem"},{"key":"10.1053\/j.jvca.2018.08.019_bib0043","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1016\/j.jtcvs.2018.02.004","article-title":"The prognostic role of natriuretic peptides in children undergoing cardiac surgery: Can acute kidney injury affect their accuracy?","volume":"155","author":"Cantinotti","year":"2018","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2018.08.019_bib0044","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jtcvs.2016.02.029","article-title":"(TRIBE-AKI Consortium), et al. Association of cardiac biomarkers with acute kidney injury after cardiac surgery: A multicenter cohort study","volume":"152","author":"Belley-C\u00f4t\u00e9","year":"2016","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2018.08.019_bib0045","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0272-6386(04)00812-1","article-title":"Diagnostic and prognostic value of plasma brain natriuretic peptide in non-dialysis-dependent CRF","volume":"44","author":"Takami","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jvca.2018.08.019_bib0046","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1016\/j.jacc.2007.09.021","article-title":"Natriuretic peptides","volume":"50","author":"Daniels","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jvca.2018.08.019_bib0047","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.ejheart.2008.07.014","article-title":"State of the art: Using natriuretic peptide levels in clinical practice","volume":"10","author":"Maisel","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"10.1053\/j.jvca.2018.08.019_bib0048","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1016\/j.jacc.2007.08.012","article-title":"Comparison of midregional pro-atrial natriuretic peptide with n-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure","volume":"50","author":"Von Haehling","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jvca.2018.08.019_bib0049","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ijcard.2008.11.149","article-title":"Natriuretic peptides and other biomarkers in chronic heart failure: From BNP, NT-proBNP, and MR-proANP to routine biochemical markers","volume":"132","author":"Lainscak","year":"2009","journal-title":"Int J Cardiol"},{"key":"10.1053\/j.jvca.2018.08.019_bib0050","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12871-016-0271-5","article-title":"Outcome of cardiac surgery in patients with low preoperative ejection fraction","volume":"16","author":"Pieri","year":"2016","journal-title":"BMC Anesthesiol"},{"key":"10.1053\/j.jvca.2018.08.019_bib0051","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1056\/NEJMoa1616218","article-title":"Levosimendan in patients with left ventricular dysfunction undergoing cardiac surgery","volume":"376","author":"Mehta","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2018.08.019_bib0052","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jama.2017.9973","article-title":"Effect of levosimendan on low cardiac output syndrome in patients with low ejection fraction undergoing coronary artery bypass grafting with cardiopulmonary bypass: The LICORN randomized clinical trial","volume":"318","author":"Cholley","year":"2017","journal-title":"J Am Med Assoc"},{"key":"10.1053\/j.jvca.2018.08.019_bib0053","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/j.athoracsur.2011.06.017","article-title":"Predictors of low cardiac output syndrome after isolated coronary artery bypass surgery: Trends over 20 years","volume":"92","author":"Algarni","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2018.08.019_bib0054","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S1010-7940(99)00106-2","article-title":"Risk factors and outcome in European cardiac surgery: Analysis of the EuroSCORE multinational database of 19030 patients","volume":"15","author":"Roques","year":"1999","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1053\/j.jvca.2018.08.019_bib0055","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0195-668X(02)00799-6","article-title":"The logistic EuroSCORE","volume":"24","author":"Roques","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1053\/j.jvca.2018.08.019_bib0056","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S0828-282X(07)70874-7","article-title":"Application of the Parsonnet scoring system for a Canadian cardiac surgery program","volume":"23","author":"De Varennes","year":"2007","journal-title":"Can J Cardiol"},{"key":"10.1053\/j.jvca.2018.08.019_bib0057","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1177\/1089253208323681","article-title":"Risk stratification models for cardiac surgery","volume":"12","author":"Granton","year":"2008","journal-title":"Semin Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2018.08.019_bib0058","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1161\/CIRCULATIONAHA.116.025795","article-title":"Ejection fraction misunderstood and overrated (changing the paradigm in categorizing heart failure)","volume":"135","author":"Konstam","year":"2017","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2018.08.019_bib0059","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1093\/icvts\/ivw224","article-title":"Performance of EuroSCORE II and SinoSCORE in Chinese patients undergoing coronary artery bypass grafting","volume":"23","author":"Bai","year":"2016","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1053\/j.jvca.2018.08.019_bib0060","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jcrc.2014.03.022","article-title":"Predictive value of plasma brain natriuretic peptide for postoperative cardiac complications \u2013 a systemic review and meta-analysis","volume":"29","author":"Young","year":"2014","journal-title":"J Crit Care"},{"key":"10.1053\/j.jvca.2018.08.019_bib0061","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1016\/j.jacc.2003.12.048","article-title":"Utility of B-type natriuretic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgery","volume":"43","author":"Hutfless","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jvca.2018.08.019_bib0062","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/ALN.0b013e318299969c","article-title":"Increased perioperative B-type natriuretic peptide associates with heart failure hospitalization or heart failure death after coronary artery bypass graft surgery","volume":"119","author":"Fox","year":"2013","journal-title":"Anesthesiology"},{"key":"10.1053\/j.jvca.2018.08.019_bib0063","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1213\/00000539-200102000-00002","article-title":"Diastolic dysfunction is predictive of difficult weaning from cardiopulmonary bypass","volume":"92","author":"Bernard","year":"2001","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2018.08.019_bib0064","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/ejcts\/ezr007","article-title":"The use of pre-operative brain natriuretic peptides as a predictor of adverse outcomes after cardiac surgery: A systematic review and meta-analysis","volume":"41","author":"Littona","year":"2012","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1053\/j.jvca.2018.08.019_bib0065","first-page":"298","article-title":"The role of brain natriuretic peptide in the prediction of cardiac performance in coronary artery bypass grafting","volume":"30","author":"Saribulbul","year":"2003","journal-title":"Tex Heart Inst J"},{"key":"10.1053\/j.jvca.2018.08.019_bib0066","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1213\/01.ANE.0000093249.35075.F1","article-title":"A-type and B-type natriuretic peptides in cardiac surgical procedures","volume":"98","author":"Berendes","year":"2004","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2018.08.019_bib0067","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S1010-7940(01)00754-0","article-title":"Plasma levels of atrial and brain natriuretic peptides as indicators of recovery of left ventricular systolic function after coronary artery bypass","volume":"20","author":"Chello","year":"2001","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1053\/j.jvca.2018.08.019_bib0068","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.jtcvs.2007.12.036","article-title":"Preoperative B-type natriuretic peptide independently predicts ventricular dysfunction and mortality after primary coronary artery bypass graft surgery","volume":"136","author":"Fox","year":"2008","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2018.08.019_bib0069","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1399-6576.2007.01451.x","article-title":"Brain natriuretic peptide is a good predictor for outcome in cardiac surgery","volume":"52","author":"El\u00edasd\u00f3ttir","year":"2008","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1053\/j.jvca.2018.08.019_bib0070","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1510\/icvts.2008.189837","article-title":"Brain natriuretic peptide a predictive marker in cardiac surgery","volume":"9","author":"Attaran","year":"2009","journal-title":"Interactive CardioVasc Thorac Surg"},{"key":"10.1053\/j.jvca.2018.08.019_bib0071","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/bja\/aep234","article-title":"N-terminal pro-B-type natriuretic peptide levels and early outcome after cardiac surgery: A prospective cohort study","volume":"103","author":"Cuthbertson","year":"2009","journal-title":"Br J Anaesth"},{"key":"10.1053\/j.jvca.2018.08.019_bib0072","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/bja\/aes379","article-title":"N-terminal pro-B-type natriuretic peptide and long-term outcome after cardiac surgery","volume":"110","author":"Cuthbertson","year":"2013","journal-title":"Br J Anaesth"},{"key":"10.1053\/j.jvca.2018.08.019_bib0073","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1749-8090-8-1","article-title":"Perioperative application of N-terminal pro-brain natriuretic peptide in patients undergoing cardiac surgery","volume":"8","author":"Liu","year":"2013","journal-title":"J Cardiothorac Surg"},{"key":"10.1053\/j.jvca.2018.08.019_bib0074","first-page":"182","article-title":"Predictors of mortality in cardiac surgery: Brain natriuretic peptide type B","volume":"30","author":"Murad","year":"2015","journal-title":"Rev Bras Cir Cardiovasc"},{"key":"10.1053\/j.jvca.2018.08.019_bib0075","doi-asserted-by":"crossref","first-page":"33","DOI":"10.6061\/clinics\/2013(01)OA05","article-title":"High levels of B-type natriuretic peptide predict weaning failure from mechanical ventilation in adult patients after cardiac surgery","volume":"68","author":"Lara","year":"2013","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1053\/j.jvca.2018.08.019_bib0076","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1053\/j.jvca.2014.11.015","article-title":"Preoperative brain natriuretic peptide and atrial arrhythmias after coronary artery bypass graft surgery","volume":"29","author":"Bernstein","year":"2015","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2018.08.019_bib0077","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1161\/01.CIR.0000134481.24511.BC","article-title":"Plasma B-type natriuretic peptide levels predict postoperative atrial fibrillation in patients undergoing cardiac surgery","volume":"110","author":"Wazni","year":"2004","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2018.08.019_bib0078","doi-asserted-by":"crossref","first-page":"375","DOI":"10.5761\/atcs.oa.12.01994","article-title":"Preoperative high N-terminal pro-B-type natriuretic peptide level can predict the incidence of postoperative atrial fibrillation following off-pump coronary artery bypass grafting","volume":"19","author":"Matsuura","year":"2013","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2018.08.019_bib0079","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.athoracsur.2009.04.021","article-title":"Utility of brain natriuretic peptide as a predictor of atrial fibrillation after cardiac operations","volume":"88","author":"Tavakol","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2018.08.019_bib0080","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1177\/0310057X0703500307","article-title":"NT-pro BNP secretion and clinical endpoints in cardiac surgery intensive care patients","volume":"35","author":"Jogia","year":"2007","journal-title":"Anaesth Intensive Care"},{"key":"10.1053\/j.jvca.2018.08.019_bib0081","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ejcts.2009.07.003","article-title":"NT-pro-BNP, but not C-reactive protein, is predictive of atrial fibrillation in patients undergoing coronary artery bypass surgery","volume":"37","author":"Gasparovic","year":"2010","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1053\/j.jvca.2018.08.019_bib0082","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/bja\/aeu088","article-title":"EuroSCORE II and N-terminal pro-B-type natriuretic peptide for risk evaluation: An observational longitudinal study in patients undergoing coronary artery bypass graft surgery","volume":"113","author":"Holm","year":"2014","journal-title":"Br J Anaesth"},{"key":"10.1053\/j.jvca.2018.08.019_bib0083","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1053\/j.jvca.2010.05.009","article-title":"Does preoperative B-type natriuretic peptide better predict adverse outcome and prolonged length of stay than the standard European System for Cardiac Operative Risk Evaluation after cardiac surgery?","volume":"25","author":"Fellahi","year":"2011","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2018.08.019_bib0084","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.amjcard.2008.04.055","article-title":"Comparison of brain natriuretic peptide plasma levels versus logistic EuroSCORE in predicting in-hospital and late postoperative mortality in patients undergoing aortic valve replacement for symptomatic aortic stenosis","volume":"102","author":"Pedrazzini","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1053\/j.jvca.2018.08.019_bib0085","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1136\/hrt.2005.074161","article-title":"Natriuretic peptides in heart valve disease","volume":"92","author":"Ray","year":"2006","journal-title":"Heart"},{"key":"10.1053\/j.jvca.2018.08.019_bib0086","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1016\/j.jacc.2004.09.038","article-title":"Wall stress modulates brain natriuretic peptide production in pressure overload cardiomyopathy","volume":"44","author":"Vanderheyden","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jvca.2018.08.019_bib0087","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0002-8703(97)70225-4","article-title":"Plasma levels of brain and atrial natriuretic peptides elevate in proportion to left ventricular end-systolic wall stress in patients with aortic stenosis","volume":"133","author":"Ikeda","year":"1997","journal-title":"Am Heart J"},{"key":"10.1053\/j.jvca.2018.08.019_bib0088","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1016\/j.ehj.2004.09.033","article-title":"Predictors of outcome in patients with severe aortic stenosis and normal left ventricular function: Role of B-type natriuretic peptide","volume":"25","author":"Lim","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1053\/j.jvca.2018.08.019_bib0089","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1161\/01.CIR.0000126825.50903.18","article-title":"Natriuretic peptides predict symptom free survival and postoperative outcome in severe aortic stenosis","volume":"109","author":"Bergler-Klein","year":"2004","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2018.08.019_bib0090","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1161\/01.CIR.0000164269.80908.9D","article-title":"B-type natriuretic peptide in organic mitral regurgitation","volume":"11","author":"Detaint","year":"2005","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2018.08.019_bib0091","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1016\/S0735-1097(03)00486-8","article-title":"Plasma natriuretic peptide levels increase with symptoms and severity of mitral regurgitation","volume":"41","author":"Sutton","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jvca.2018.08.019_bib0092","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1042\/cs0870671","article-title":"Plasma atrial and brain natriuretic peptides in mitral stenosis treated by valvulotomy","volume":"87","author":"Tharaux","year":"1994","journal-title":"Clin Sci"},{"key":"10.1053\/j.jvca.2018.08.019_bib0093","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0002-8703(89)90783-7","article-title":"Rapid fall in elevated plasma atrial natriuretic peptide levels after successful catheter balloon valvuloplasty of mitral stenosis","volume":"117","author":"Hung","year":"1989","journal-title":"Am Heart J"},{"key":"10.1053\/j.jvca.2018.08.019_bib0094","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/0002-8703(92)90413-P","article-title":"Relationship between plasma atrial and brain natriuretic peptide concentration and haemodynamic parameters during percutaneous transvenous mitral valvotomy in patients with mitral stenosis","volume":"124","author":"Nakamura","year":"1992","journal-title":"Am Heart J"},{"key":"10.1053\/j.jvca.2018.08.019_bib0095","first-page":"11","article-title":"N-Brain natriuretic peptide and acute coronary syndrome","volume":"96","author":"Mazzone","year":"2005","journal-title":"Minerva Med"},{"key":"10.1053\/j.jvca.2018.08.019_bib0096","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s10741-014-9422-2","article-title":"The potential and limitations of plasma BNP measurement in the diagnosis, prognosis, and management of children with heart failure due to congenital cardiac disease: An update","volume":"19","author":"Cantinotti","year":"2014","journal-title":"Heart Fail Rev"},{"key":"10.1053\/j.jvca.2018.08.019_bib0097","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/eurheartj\/ehi773","article-title":"B-type natriuretic peptide in paediatric patients with congenital heart disease","volume":"27","author":"Koch","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1053\/j.jvca.2018.08.019_bib0098","doi-asserted-by":"crossref","first-page":"719","DOI":"10.4330\/wjc.v8.i12.719","article-title":"Cardiac biomarkers in pediatric heart disease: A state of art review","volume":"8","author":"Fernandes","year":"2016","journal-title":"World J Cardiol"},{"key":"10.1053\/j.jvca.2018.08.019_bib0099","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1475-097X.2005.00622.x","article-title":"Increased plasma levels of natriuretic peptide type B and A in children with congenital heart defects with left compared with right ventricular volume overload or pressure overload","volume":"25","author":"Holmgren","year":"2005","journal-title":"Clin Physiol Funct Imaging"},{"key":"10.1053\/j.jvca.2018.08.019_bib0100","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1515\/cclm-2014-1084","article-title":"Prognostic role of BNP in children undergoing surgery for congenital heart disease: Analysis of prediction models incorporating standard risk factors","volume":"53","author":"Cantinotti","year":"2015","journal-title":"Clin Chem Lab Med"},{"key":"10.1053\/j.jvca.2018.08.019_bib0101","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1053\/j.jvca.2016.09.008","article-title":"Perioperative brain natriuretic peptide in pediatric cardiac surgery patients: Its association with postoperative outcomes","volume":"31","author":"Kanazawa","year":"2017","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2018.08.019_bib0102","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1016\/j.jtcvs.2018.02.074","article-title":"Relationship between perioperative N-terminal pro-brain natriuretic peptide and maximum inotropic score in children after cardiac surgery","volume":"155","author":"Cui","year":"2018","journal-title":"Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2018.08.019_bib0103","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s00134-008-1025-8","article-title":"Value of brain natriuretic peptide in the perioperative follow-up of children with valvular disease","volume":"34","author":"Tissi\u00e8res","year":"2008","journal-title":"Intensive Care Med"},{"key":"10.1053\/j.jvca.2018.08.019_bib0104","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jtcvs.2016.12.056","article-title":"Perioperative NT-proBNP level: Potential prognostic markers in children undergoing congenital heart disease surgery","volume":"154","author":"Qu","year":"2017","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2018.08.019_bib0105","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1016\/j.jtcvs.2018.01.037","article-title":"Potential usefulness of N-terminal pro-brain natriuretic peptide level in congenital heart surgery","volume":"155","author":"Monaghan","year":"2018","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2018.08.019_bib0106","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0009-8981(97)06518-2","article-title":"Augmented release of brain natriuretic peptide during reperfusion of the human heart after cardioplegic cardiac arrest","volume":"261","author":"Mair","year":"1997","journal-title":"Clin Chim Acta"},{"key":"10.1053\/j.jvca.2018.08.019_bib0107","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1161\/CIRCULATIONAHA.113.007253","article-title":"Troponin T and B-type natriuretic peptide after on-pump cardiac surgery","volume":"130","author":"Lurati Buse","year":"2014","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2018.08.019_bib0108","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1053\/j.jvca.2010.07.002","article-title":"Postoperative increase in B-type natriuretic peptide levels predicts adverse outcome after cardiac surgery","volume":"25","author":"Nozohoor","year":"2011","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2018.08.019_bib0109","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1213\/ANE.0000000000002291","article-title":"Absolute postoperative B-type natriuretic peptide concentrations, but not their general trend, are associated with 12-month, all-cause mortality after on-pump cardiac surgery","volume":"125","author":"Mauermann","year":"2017","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2018.08.019_bib0110","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/ALN.0b013e31820ef9c1","article-title":"Elevated peak postoperative b-type natriuretic peptide predicts decreased longer-term physical function after primary coronary artery bypass graft surgery","volume":"114","author":"Fox","year":"2011","journal-title":"Anesthesiology"},{"key":"10.1053\/j.jvca.2018.08.019_bib0111","doi-asserted-by":"crossref","first-page":"6761","DOI":"10.3892\/mmr.2015.4247","article-title":"Increased B-type-natriuretic peptide promotes myocardial cell apoptosis via the B-type natriuretic peptide\/long non-coding rna lsinct5\/caspase-1\/interleukin 1\u03b2 signaling pathway","volume":"12","author":"Zhang","year":"2015","journal-title":"Mol Med Rep"},{"key":"10.1053\/j.jvca.2018.08.019_bib0112","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.cardfail.2012.10.008","volume":"18","author":"Perna","year":"2012","journal-title":"J Card Fail"},{"key":"10.1053\/j.jvca.2018.08.019_bib0113","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1161\/hc0502.104278","article-title":"Minor myocardial damage and prognosis are spontaneous and percutaneous coronary intervention\u2013related events different?","volume":"105","author":"Akkerhuis","year":"2002","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2018.08.019_bib0114","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/bja\/ael271","article-title":"B-type natriuretic peptide to assess haemodynamic status after cardiac surgery","volume":"97","author":"Mekontso-Dessap","year":"2006","journal-title":"Br J Anaesth"},{"key":"10.1053\/j.jvca.2018.08.019_bib0115","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jacc.2009.02.095","article-title":"N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: Results from the BATTLESCARRED (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trial","volume":"55","author":"Lainchbury","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jvca.2018.08.019_bib0116","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40560-016-0148-1","article-title":"Sepsis-induced myocardial dysfunction: Pathophysiology and management","volume":"4","author":"Kakihana","year":"2016","journal-title":"J Intensive Care"},{"key":"10.1053\/j.jvca.2018.08.019_bib0117","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s40779-016-0099-9","article-title":"Pathophysiology of sepsis-induced myocardial dysfunction","volume":"3","author":"Lv","year":"2016","journal-title":"Mil Med Res"},{"key":"10.1053\/j.jvca.2018.08.019_bib0118","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jcrc.2017.07.009","article-title":"The prognostic value of brain natriuretic peptide (BNP) in non-cardiac patients with sepsis, ultra-long follow-up","volume":"42","author":"Khoury","year":"2017","journal-title":"J Crit Care"},{"key":"10.1053\/j.jvca.2018.08.019_bib0119","doi-asserted-by":"crossref","first-page":"R74","DOI":"10.1186\/cc11331","article-title":"Brain natriuretic peptide for prediction of mortality in patients with sepsis: A systematic review and meta-analysis","volume":"16","author":"Wang","year":"2012","journal-title":"Crit Care"},{"key":"10.1053\/j.jvca.2018.08.019_bib0120","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1007\/s00134-014-3367-8","article-title":"Understanding cardiac failure in sepsis","volume":"40","author":"Vieillard-Baron","year":"2014","journal-title":"Intensive Care Med"},{"key":"10.1053\/j.jvca.2018.08.019_bib0121","first-page":"219","article-title":"Relationship between B-type natriuretic peptide and adverse outcome in patients with clinical evidence of sepsis presenting to the emergency department","volume":"18","author":"Perman","year":"2011","journal-title":"Acad Emerg Med"},{"key":"10.1053\/j.jvca.2018.08.019_bib0122","first-page":"R254","article-title":"Initial externalization followed by internalization of beta-adrenergic receptors in rat heart during sepsis","volume":"270","author":"Tang","year":"1996","journal-title":"Am J Physiol"},{"key":"10.1053\/j.jvca.2018.08.019_bib0123","first-page":"H410","article-title":"Myocardial adrenergic responsiveness after lethal and nonlethal doses of endotoxin","volume":"252","author":"Shepherd","year":"1987","journal-title":"Am J Physiol"},{"key":"10.1053\/j.jvca.2018.08.019_bib0124","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/SHK.0b013e318277109c","article-title":"PAMPS and the origins of SIRS in bacterial sepsis","volume":"39","author":"Gentile","year":"2013","journal-title":"Shock"},{"key":"10.1053\/j.jvca.2018.08.019_bib0125","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1093\/eurheartj\/ehr351","article-title":"Diastolic dysfunction and mortality in severe sepsis and septic shock","volume":"33","author":"Landesberg","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1053\/j.jvca.2018.08.019_bib0126","first-page":"183","article-title":"The prognostic value of atrial and brain natriuretic peptides, troponin I and C-reactive protein in patients with sepsis","volume":"13","author":"Yucel","year":"2008","journal-title":"Exp Clin Cardiol"},{"key":"10.1053\/j.jvca.2018.08.019_bib0127","first-page":"293","article-title":"Prognostic values of B-type natriuretic peptide in severe sepsis and septic shock","volume":"21","author":"Zhao","year":"2009","journal-title":"Zhongguo Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"10.1053\/j.jvca.2018.08.019_bib0128","doi-asserted-by":"crossref","first-page":"418","DOI":"10.5114\/aoms.2015.54196","article-title":"Comparison of prognostic value of N-terminal pro-brain natriuretic peptide in septic and non-septic intensive care patients","volume":"13","author":"Ozcan","year":"2017","journal-title":"Arch Med Sci"},{"key":"10.1053\/j.jvca.2018.08.019_bib0129","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1016\/j.jcrc.2014.12.008","article-title":"N-terminal pro-brain natriuretic peptide and cardiac troponin I for the prognostic utility in elderly patients with severe sepsis or septic shock in intensive care unit: A retrospective study","volume":"30","author":"Cheng","year":"2015","journal-title":"J Crit Care"},{"key":"10.1053\/j.jvca.2018.08.019_bib0130","doi-asserted-by":"crossref","first-page":"R37","DOI":"10.1186\/cc4839","article-title":"Natriuretic peptide testing for the evaluation of critically ill patients with shock in the intensive care unit: A prospective cohort study","volume":"10","author":"Januzzi","year":"2006","journal-title":"Crit Care"},{"key":"10.1053\/j.jvca.2018.08.019_bib0131","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1177\/0300060515583077","article-title":"Validation of circulating BNP level >1000\u2009pg\/ml in all-cause mortality: A retrospective study","volume":"43","author":"Sakamoto","year":"2015","journal-title":"J Int Med Res"},{"key":"10.1053\/j.jvca.2018.08.019_bib0132","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1378\/chest.11-0824","article-title":"Direct comparison of three natriuretic peptides for prediction of short- and long-term mortalityin patients with community-acquired pneumonia","volume":"141","author":"Nowak","year":"2012","journal-title":"Chest"},{"key":"10.1053\/j.jvca.2018.08.019_bib0133","article-title":"Validation of a B-type natriuretic peptide as a prognostic marker in pneumonia patients: A prospective cohort study","volume":"6","author":"Usuda","year":"2016","journal-title":"Br Med J Open"},{"key":"10.1053\/j.jvca.2018.08.019_bib0134","first-page":"626","article-title":"Analysis of the severity and prognosis assessment of aged patients with community-acquired pneumonia: A retrospective study","volume":"5","author":"Xiao","year":"2013","journal-title":"J Thorac Dis"},{"key":"10.1053\/j.jvca.2018.08.019_bib0135","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/j.ajem.2015.06.036","article-title":"Is there a potential role for echocardiography in adult patients with CAP?","volume":"33","author":"Yildirim","year":"2015","journal-title":"Am J Emerg Med"},{"key":"10.1053\/j.jvca.2018.08.019_bib0136","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1056\/NEJMoa010307","article-title":"Early goal-directed therapy in the treatment of severe sepsis and septic shock","volume":"345","author":"Rivers","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2018.08.019_bib0137","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1093\/eurheartj\/ehu090","article-title":"Effect of B-type natriuretic peptide-guided treatment of chronic heart failure on total mortality and hospitalization: An individual patient meta-analysis","volume":"35","author":"Troughton","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1053\/j.jvca.2018.08.019_bib0138","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1136\/hrt.72.5.422","article-title":"Neurohormonal activation in patients with mild or moderately severe congestive heart failure and effect of ramipril","volume":"72","author":"Sigurdsson","year":"1994","journal-title":"Br Heart J"},{"key":"10.1053\/j.jvca.2018.08.019_bib0139","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/S0140-6736(00)02060-2","article-title":"Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations","volume":"355","author":"Troughton","year":"2000","journal-title":"Lancet"},{"key":"10.1053\/j.jvca.2018.08.019_bib0140","doi-asserted-by":"crossref","first-page":"96","DOI":"10.15420\/cfr.2015.1.2.96","article-title":"Biomarker-guided therapy in chronic heart failure","volume":"1","author":"Brunner-La Rocca","year":"2015","journal-title":"Card Fail Rev"},{"key":"10.1053\/j.jvca.2018.08.019_bib0141","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3109\/14017431.2015.1070961","article-title":"Responder to BNP-guided treatment in heart failure. The process of defining a responder. Results from the use of peptides in tailoring heart failure project or UPSTEP study","volume":"49","author":"Karlstr\u00f6m","year":"2015","journal-title":"Scand Cardiovasc J"},{"key":"10.1053\/j.jvca.2018.08.019_bib0142","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1001\/jama.2017.10565","article-title":"Effect of natriuretic peptide-guided therapy on hospitalization or cardiovascular mortality in high-risk patients with heart failure and reduced ejection fraction: A randomized clinical trial","volume":"318","author":"Felker","year":"2017","journal-title":"J Am Med Assoc"},{"key":"10.1053\/j.jvca.2018.08.019_bib0143","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1161\/CIRCULATIONAHA.117.029882","article-title":"NT-proBNP-guided therapy in acute decompensated heart failure: The PRIMA II randomized controlled trial","volume":"137","author":"Stienen","year":"2018","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2018.08.019_bib0144","first-page":"208","article-title":"Can natriuretic peptides be used to guide therapy?","volume":"27","author":"Bayes-Genis","year":"2016","journal-title":"J Int Fed Clin Chem"},{"key":"10.1053\/j.jvca.2018.08.019_bib0145","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ijcard.2008.01.034","article-title":"Natriuretic peptide-guided levosimendan therapy for heart failure: A promising new approach","volume":"128","author":"Giamouzis","year":"2008","journal-title":"Int J Cardiol"},{"key":"10.1053\/j.jvca.2018.08.019_bib0146","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/FJC.0000000000000533","article-title":"Levosimendan in acute and advanced heart failure: An appraisal of the clinical database and evaluation of its therapeutic applications","volume":"71","author":"Altenberger","year":"2018","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1053\/j.jvca.2018.08.019_bib0147","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/ejhf.118","article-title":"Efficacy and safety of the pulsed infusions of levosimendan in outpatients with advanced heart failure (Levo-Rep) study: A multicentre randomized trial","volume":"16","author":"Altenberger","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"10.1053\/j.jvca.2018.08.019_bib0148","first-page":"125","article-title":"Preoperative levosimendan decreases mortality and the development of low cardiac output in high-risk patients with severe left ventricular dysfunction undergoing coronary artery bypass grafting with cardiopulmonary bypass","volume":"17","author":"Levin","year":"2012","journal-title":"Exp Clin Cardiol"},{"key":"10.1053\/j.jvca.2018.08.019_bib0149","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1053\/j.jvca.2011.03.001","article-title":"Levosimendan versus intra-aortic balloon pump in high-risk cardiac surgery patients","volume":"25","author":"Severi","year":"2011","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2018.08.019_bib0150","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1053\/j.jvca.2011.09.006","article-title":"Levosimendan versus an intra-aortic balloon pump in high-risk cardiac patients","volume":"26","author":"Lomivorotov","year":"2012","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2018.08.019_bib0151","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/FJC.0000000000000551","article-title":"Use of levosimendan in cardiac surgery: An update after the LEVO-CTS, CHEETAH, and LICORN trials in the light of clinical practice","volume":"71","author":"Guarracino","year":"2018","journal-title":"J Cardiovasc Pharmacol"},{"issue":"Suppl I","key":"10.1053\/j.jvca.2018.08.019_bib0152","first-page":"216","article-title":"Low NT-proBNP response to levosimendan is associated with mortality in coronary surgery for ischaemic cardiomyopathy","volume":"16","author":"Krichevskiy","year":"2012","journal-title":"Appl Cardiopulm Pathophysiol"},{"key":"10.1053\/j.jvca.2018.08.019_bib0153","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1056\/NEJM200007273430403","article-title":"Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure","volume":"343","author":"Colucci","year":"2000","journal-title":"Nesiritide Study Group. N Engl J Med"},{"key":"10.1053\/j.jvca.2018.08.019_bib0154","article-title":"Efficacy and safety of nesiritide in patients with decompensated heart failure: A meta-analysis of randomised trials","volume":"6","author":"Gong","year":"2016","journal-title":"Br Med J Open"},{"key":"10.1053\/j.jvca.2018.08.019_bib0155","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1161\/01.CIR.0000159340.93220.E4","article-title":"Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure","volume":"111","author":"Sackner-Bernstein","year":"2005","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2018.08.019_bib0156","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1253\/circj.CJ-66-0068","article-title":"Guidelines for treatment of acute heart failure (JCS 2011)","volume":"77","year":"2013","journal-title":"Circ J"},{"key":"10.1053\/j.jvca.2018.08.019_bib0157","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jjcc.2015.09.011","article-title":"Natriuretic peptides for perioperative management of cardiac surgery","volume":"67","author":"Sezai","year":"2016","journal-title":"J Cardiol"},{"key":"10.1053\/j.jvca.2018.08.019_bib0158","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1016\/S0735-1097(01)01233-5","article-title":"Intravenous atrial natriuretic peptide prevents left ventricular remodeling in patients with first anterior acute myocardial infarction","volume":"37","author":"Hayashi","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jvca.2018.08.019_bib0159","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jacc.2006.09.048","article-title":"Effects of intravenous atrial natriuretic peptide on cardiac sympathetic nerve activity and left ventricular remodeling in patients with first anterior acute myocardial infarction","volume":"49","author":"Kasama","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jvca.2018.08.019_bib0160","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1253\/circj.67.443","article-title":"Administration of atrial natriuretic peptide attenuates reperfusion phenomena and preserves left ventricular regional wall motion after direct coronary angioplasty for acute myocardial infarction","volume":"67","author":"Kuga","year":"2003","journal-title":"Circ J"},{"key":"10.1053\/j.jvca.2018.08.019_bib0161","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/00005344-200007000-00003","article-title":"Alpha human atrial natriuretic peptide, carperitide, reduces infarct size but not arrhythmias after coronary occlusion\/reperfusion in dogs","volume":"36","author":"Takagi","year":"2000","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1053\/j.jvca.2018.08.019_bib0162","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/S0003-4975(99)01305-3","article-title":"Low-dose continuous infusion of human atrial natriuretic peptide during and after cardiac surgery","volume":"69","author":"Sezai","year":"2000","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2018.08.019_bib0163","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.jacc.2009.05.047","article-title":"Influence of continuous infusion of low dose human atrial natriuretic peptide on renal function during cardiac surgery: A randomized controlled study","volume":"54","author":"Sezai","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jvca.2018.08.019_bib0164","doi-asserted-by":"crossref","first-page":"217","DOI":"10.5761\/atcs.oa.13.02252","article-title":"Early results of human atrial natriuretic peptide infusion in non-dialysis patients with chronic kidney disease undergoing isolated coronary artery bypass grafting: The NU-HIT trial for CKD-II","volume":"20","author":"Sezai","year":"2014","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2018.08.019_bib0165","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1016\/j.jacc.2009.11.085","volume":"55","author":"Sezai","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jvca.2018.08.019_bib0166","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1136\/heartjnl-2017-311295","article-title":"Sacubitril\/valsartan: Beyond natriuretic peptides","volume":"103","author":"Singh","year":"2017","journal-title":"Heart"},{"key":"10.1053\/j.jvca.2018.08.019_bib0167","first-page":"383","article-title":"Vasopeptidase inhibition","volume":"41","author":"Campbell","year":"2003","journal-title":"A double-edge sword? Hypertension"},{"key":"10.1053\/j.jvca.2018.08.019_bib0168","first-page":"83","article-title":"Dual inhibition of ACE and NEP provides greater cardioprotection in mice with heart failure","volume":"10","author":"Xu","year":"2004","journal-title":"J Card Fail"}],"container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077018306542?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077018306542?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T03:11:55Z","timestamp":1661742715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053077018306542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":168,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S1053077018306542"],"URL":"https:\/\/doi.org\/10.1053\/j.jvca.2018.08.019","relation":{},"ISSN":["1053-0770"],"issn-type":[{"type":"print","value":"1053-0770"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natriuretic Peptides in Cardiac Anesthesia and Intensive Care","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiothoracic and Vascular Anesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.jvca.2018.08.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}